Navigation Links
Hooper Holmes Announces First Quarter 2008 Results
Date:5/9/2008

ding physician statement (APS) orders received from customers

during the quarter.

-- Heritage Labs revenues remained flat at $4.5 million for the three

month periods ended March 31, 2008 and 2007.

-- Health & Wellness revenues were $1.9 million, up significantly compared

to $0.4 million in the first quarter of 2007. This increase is a

result of the growth in new customers since the division's inception in

early 2007.

-- Underwriting Solutions revenues decreased 23.0% to $2.9 million

compared to $3.8 million in the first quarter of 2007. The decrease is

due to the loss in volume from one major customer, partially offset by

revenue from new clients.

Claims Evaluation Division (CED)

The CED reported first quarter revenues of $6.7 million, a decrease of 15.0% compared to $7.9 million in the first quarter of 2007. The decrease was primarily the result of a continued contraction in the number of independent medical exams ordered by our customers.

Roy H. Bubbs, President and Chief Executive Officer of Hooper Holmes, commented, "Our performance in the first quarter reflects improved gross margins and reduced SG&A as a result of the financial discipline we continue to drive throughout the organization. Over the course of 2008, we will continue our efforts to strengthen Portamedic, leverage the synergies among our businesses, and look forward to introducing new market offerings that we believe will play an integral part in our future success. We have identified numerous opportunities for improving our Company and we are working diligently toward addressing them."

Conference Call

The Company will host a conference call, today, May 9, 2008 at 11:00 a.m. Eastern Time to discuss first quarter 2008 financial results.

To participate in the conference call, please dial (888) 790-3758 or (210) 839-8398, passcode: Hooper Holmes. A live web cast will be h
'/>"/>

SOURCE Hooper Holmes, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman
2. Hooper Holmes Announces Fourth Quarter Earnings Release Date and Conference Call Information
3. Hooper Holmes to Provide Business Update
4. Hooper Holmes Updates Guidance
5. Hooper Holmes Marks 50,000 Health and Wellness Screenings
6. Hooper Holmes Announces Third Quarter 2007 Results
7. Hooper Holmes Appoints Leslie Hudson, PhD, to Board of Directors
8. Hooper Holmes Announces Third Quarter Earnings Release Date and Conference Call Information
9. Hooper Holmes Introduces Mature Assessment
10. Hooper Holmes to Exhibit at the 2007 Sixth Annual Association of Home Office Underwriters Conference
11. Hooper Holmes Concludes Sale of Medicals Direct
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... BostonPractices used in policing injection drug users in ... mortality. , A study, conducted by researchers ... Health, in collaboration with St. Petersburg Pavlov State ... had on the health outcomes of a cohort ... use. , Those who were arrested by police ...
(Date:7/9/2014)... (July 8, 2014) Researchers from Montefiore Medical ... Medicine of Yeshiva University will present new findings ... July 12 July 17 in Copenhagen, Denmark. Data ... could prompt transition from cognitive normality to mild cognitive ... Einstein Aging Study , established in 1980 to ...
(Date:7/9/2014)... is one of the most important organs in the ... utilize our food properly this is its synthesis ... our organism this is its detoxification function. Lack ... food all damage the liver. The resulting diseased cells ... and life-threatening liver failure. According to the German Liver ...
(Date:7/9/2014)... A study published in the scientific journal ... Bonin, two researchers at Universit Laval, reveals that it ... method that involves rekindling pain so that it can ... means to alleviate chronic pain. , The researchers from ... universitaire en sant mentale de Qubec (IUSMQ) were inspired ...
(Date:7/8/2014)... Calif. The Department of Defense,s Defense Advanced ... Laboratory (LLNL) up to $2.5 million to develop ... record and stimulate neurons within the brain to ... , The research builds on the understanding that ... certain regions of the brain encode information, store ...
Breaking Medicine News(10 mins):Health News:BU researchers relate arrests with HIV risk environment 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 3Health News:Telemedicine for patients with chronic liver diseases 2Health News:Telemedicine for patients with chronic liver diseases 3Health News:Discovery of a new means to erase pain 2Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 2Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 3
... confirms previous studies showing that a high-protein diet can ... carbohydrate diet. Researchers have also demonstrated that when both ... diet is still more effective at reducing body fat. ... effect when a protein-rich diet is combined with exercise ...
... extract adult stem cells from adipose or fatty tissues ... ,International scientists will announce findings from a significant number ... tissue could eventually be used to treat injured or ... the third annual International Fat Applied Technology Society conference, ...
... is none which is not a poison; the right ... 1538 ,Breathlessness can have a major impact on ... //Despite the best efforts of scientists for many years, ... to deal with the sensation of breathlessness without suppressing ...
... remains, may be at the root of bovine spongiform ... the latest issue of The Lancet had forwarded this ... case or cases of BSE is currently unknown. Sheep ... (TSE) that arose spontaneously has long been considered as ...
... men got their share from women in the inheritance of cancer ... breast and ovarian cancers also significantly increases the danger of some ... ,Genetic mechanisms have been examined in the familial inheritance of ... is associated with increased risk in women who have a family ...
... urging countries to intensify surveillance and prepare for emergencies due ... countries to Europe, Middle East and Africa.// Though the initial ... chances of the virus may mutate and may cause infections ... dangerous and requires immediate control and elimination of the virus ...
Cached Medicine News:Health News:A Protein-Rich Diet Combined With Exercise Found To Be More Effective In Weight Loss 2Health News:Adult Stem Cells From Fat Tissues For Healing 2Health News:Mad Cow Disease Has Roots Traceable To Man 2Health News:Genes responsible for cancer in women associated with increased cancer risk in men 2
(Date:1/15/2014)... -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, 2013-2015" ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from aging ... China,s orthopedic instrument industry has seen rapid ... from 3.28 billion yuan in 2006 to 9.85 billion ...
(Date:1/15/2014)... As health officials across the Midwest warn against the widespread ... Michigan will offer free diagnostic testing for ... to administer tests and, in some cases, fill the matching ... the study. The Grand Rapids, Mich. ...
(Date:1/15/2014)... , Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... commitments from institutional investors to purchase an aggregate of ... an at-the-market registered direct offering, led by a dedicated ... definitive purchase agreements with these investors pursuant to which ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
... Feb. 24, 2011 HeartWare International, Inc. (Nasdaq: ... less invasive, miniaturized circulatory support technologies that are revolutionizing ... of $20.9 million for the fourth quarter ended December ... for the fourth quarter of 2009, and revenues of ...
... N.J. and EMERYVILLE, Calif., Feb. 24, 2011 ... ONXX ) today announced the companies ... randomized, double-blind, placebo-controlled trial evaluating Nexavar® (sorafenib) tablets ... versus placebo plus capecitabine for the treatment of ...
Cached Medicine Technology:HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 2HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 3HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 4HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 5HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 6Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer 2Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer 3Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer 4Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer 5Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer 6Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer 7
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: